DISEASE INDICATIONS: Rheumatoid Arthritis

MANUFACTURER: Eli Lilly Nederland B.V.

USAGE: Oral

MEDICINE APPROVED BY: European Medical Agency (EMA)

Olumiant (baricitinib) is an oral medication that inhibits the activity of Janus kinases to reduce inflammation and improve joint pain, swelling, and stiffness in adults with moderate to severe rheumatoid arthritis.